2-Azocinamine,N-(2-furanylphenylmethyl)-3,4,5,6,7,8-hexahydro-, hydrochloride (1:1) (53387-49-8)

Identification
Name:	2-Azocinamine,N-(2-furanylphenylmethyl)-3,4,5,6,7,8-hexahydro-, hydrochloride (1:1)
Synonyms:	2-Azocinamine,N-(2-furanylphenylmethyl)-3,4,5,6,7,8-hexahydro-, monohydrochloride (9CI); NSC211499
CAS:	53387-49-8
Molecular Formula:	C18H22 N2 O . Cl H
Molecular Weight:	282.3801
InChI:	InChI=1/C18H22N2O/c1-2-7-13-19-17(12-6-1)20-18(16-11-8-14-21-16)15-9-4-3-5-10-15/h3-5,8-11,14,18H,1-2,6-7,12-13H2,(H,19,20)
Molecular Structure:
Properties
Flash Point:	224.5°C
Boiling Point:	447.7°C at 760 mmHg
Density:	1.11g/cm³
Refractive index:	1.59
Flash Point:	224.5°C
Safety Data

Other Product

1(2H)-Azocinamine, hexahydro-
1(2H)-Azocinamine,hexahydro-N,N-dimethyl-
2-Azocinamine, N-(cyclopropylphenylmethyl)-3,4,5,6,7,8-hexahydro-,monohydrochloride
Benzenesulfonamide, N-(2-furanylphenylmethyl)-4-methyl-
1-Azabicyclo[2.2.2]octan-3-amine,2-(2-furanylphenylmethyl)-N-[(2-methoxyphenyl)methyl]-
1-Azabicyclo[2.2.2]octan-3-amine,2-(2-furanylphenylmethyl)-N-(phenylmethyl)-
Benzamide,3-[[2-[(2-furanylphenylmethyl)amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]-2-hydroxy-N,N-dimethyl-
3-Quinolinecarboxylic acid,8-chloro-1-cyclopropyl-6-fluoro-7-(hexahydro-2-methylpyrrolo[3,4-b]pyrrol-5(1H)-yl)-1,4-dihydro-4-oxo-, hydrochloride
Spiro[3H-indole-3,1'(5'H)-indolizin]-2(1H)-one,6'-ethyl-2',3',6',7',8',8'a-hexahydro-7'-(2-hydroxyethyl)-, (1'S,6'R,7'R,8'aS)-
2,6-Methano-3-benzazocin-8-ol,6-ethyl-1,2,3,4,5,6-hexahydro-3-(2-phenylethyl)-, hydrochloride (1:1)
(2S)-4'aβ,5',6',7',8',8'a-Hexahydro-2',5',5',8'aα-tetramethylspiro[benzofuran-2(3H),1'(4'H)-naphthalen]-5-ol
3-Quinolinecarboxylic acid,8-chloro-1-cyclopropyl-6-fluoro-7-(hexahydro-1-methylpyrrolo[3,4-b]pyrrol-5(1H)-yl)-1,4-dihydro-4-oxo-, hydrochloride
3-Quinolinecarboxylic acid,8-chloro-1-cyclopropyl-6-fluoro-7-(hexahydro-1,2-dimethylpyrrolo[3,4-b]pyrrol-5(1H)-yl)-1,4-dihydro-4-oxo-, hydrochloride
Spiro[cyclopropane-1,2'(1'H)-phenanthrene]-2-carboxaldehyde,3',4'b,5',6',8'a,9'-hexahydro-4',9'-dihydroxy-4'b,7',8'-trimethyl-1',3'-dioxo-,(1R,4'bS,8'aS,9'R)- (9CI)
1/C8H6Cl2/c9-8(10)7-5-3-1-2-4-6-7/h1-6
(1S,2R,4'aβ,6S,7'S,9a'S)-6-(Acetyloxy)-4'a,5',6',7',8',9'-hexahydro-5'α-hydroxy-3,3-dimethyl-8'-methylene-1',9'-dioxospiro[cyclohexane-1,4'(3'H)-[1H-7,9a]methanocyclohepta[c]pyran]-2-carbaldehyde
7-[7(S)-Amino-5-azaspiro[2.4]hept-5-yl]-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate
Pyrazino[1,2-a][1,4]benzodiazepine,1,2,3,4,4a,5-hexahydro-3-(3-methylbutyl)-7-(2-thienyl)-, hydrochloride (1:2)
1/C8H5F3O/c9-8(10,11)7-3-1-2-6(4-7)5-12/h1-5
1/C8H5BrCl2/c9-7-3-1-6(2-4-7)5-8(10)11/h1-5